Поисковый запрос: (<.>S=ПЕПТИДНЫЕ ВАКЦИНЫ<.>) |
Общее количество найденных документов : 36
Показаны документы с 1 по 20
|
|
1.
| A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules // Biomaterials, 2009. Vol. 30, N 28.-С.5178-5186
|
2.
| A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules // Biomaterials, 2009. Vol. 30, N 28.-С.5178-5186
|
3.
| A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years // Proc. Nat. Acad. Sci. USA, 1994. Vol. 91, N 20.-С.9588-9592
|
4.
| A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years // Proc. Nat. Acad. Sci. USA, 1994. Vol. 91, N 20.-С.9588-9592
|
5.
| AIDS-related developments.. // Appl. Genet. News, 1988. Vol. 8, N 10.-С.8-11
|
6.
| Construction of candidate synthetic peptide vaccines for HIV-1 // Vaccines'94: Mod. Approaches New Vaccines Includ. Prev. AIDS. -Cold Spring Harbor (N.Y.), 1994.-С.147-153
|
7.
| Construction of candidate synthetic peptide vaccines for HIV-1 // Vaccines'94: Mod. Approaches New Vaccines Includ. Prev. AIDS. -Cold Spring Harbor (N.Y.), 1994.-С.147-153
|
8.
| CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines // J. Virol., 1999. Vol. 73, N 5.-С.4120-4126
|
9.
| Berzofsky Jay A. Designing anti-viral synthetic peptide vaccines // J. Cell. Biochem., 1994, Suppl. 18С.-С.212
|
10.
| Developing synthetic peptide vaccines for HIV-1 // Vaccines'95: Mol. Approaches Contr. Infec. Diseases. -Cold Spring Harbor (N. Y.), 1995.-С.135-142
|
11.
| Developing synthetic peptide vaccines for HIV-1 // Vaccines'95: Mol. Approaches Contr. Infec. Diseases. -Cold Spring Harbor (N. Y.), 1995.-С.135-142
|
12.
| Development of a synthetic peptide vaccine against measles: Protection against measles and canine distemper and bypass of suppression by maternal antibody // Vaccines'94. -Cold Spring Harbor (N.Y.), 1994.-С.41-45
|
13.
| Development of a synthetic peptide vaccine against measles: Protection against measles and canine distemper and bypass of suppression by maternal antibody // Vaccines'94. -Cold Spring Harbor (N.Y.), 1994.-С.41-45
|
14.
| Yanamishi Development of new vaccine manufacturing techniques // Asian Med. J., 1995. Vol. 38, N 1.-С.1-6
|
15.
| Identification of T-cell epitopes from human rhinovirus for use in synthetic peptide vaccines // Vaccines'92: Mod. Approaches New Vaccines Inslund. Prev. AJDS. -Cold Spring Harbor (N. J.), 1992.-С.259-264
|
16.
| Villarrubia Vicente G. Las nuavas vacunas y la respuesta inmunologica I: La memoria inmunologica. Respuesta humoral frente a respuesta celular // Med. clin., 1996. Vol. 107, N 4.-С.146-154
|
17.
| Thabaut A. Les nouveaux vaccins // Lett. infec. microbiol. clin., 1992. Vol. 7, N 12.-С.413-415
|
18.
| Melief C.J.M. Lessons from T cell responses to virus induced tumours for cancer eradication in general // New Look Tumour Immunol.. -Cold Spring Harbor (N. Y.), 1992.-С.81-99
|
19.
| Mass spectrometry and peptide-based vaccine development // Clin. Pharmacol. and Ther., 2007. Vol. 82, N 6.-С.644-652
|
20.
| Peptide immunization in humans: A combined CD8{+}/CD4{+} T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL) // Clin. and Exp. Immunol., 1996. Vol. 105, N 1.-С.18-25
|
&uf('+1W2226#',v2226), ?>
|
|